This site is intended for health professionals only

Editor’s pick

Zometa reduces risk of breast cancer recurrence
Zometa reduces risk of breast cancer recurrence
Novartis gains worldwide rights to elinogrel
Novartis gains worldwide rights to elinogrel
Factor VIII concentrates for treatment of haemophilia A in Europe
Factor VIII concentrates for treatment of haemophilia A in Europe
Cancer movement mechanism explored
Cancer movement mechanism explored
Systagenix appoints president of Europe
Systagenix appoints president of Europe
Boost for prostate cancer treatment
Boost for prostate cancer treatment
UCB sells anti-haemorrhagic drug to Eumedica
UCB sells anti-haemorrhagic drug to Eumedica
Green light from the FDA for the CDC7 inhibitor
Green light from the FDA for the CDC7 inhibitor
Thousands of NHS staff “carrying MRSA”
Thousands of NHS staff “carrying MRSA”
Lundbeck to acquire Ovation Pharmaceuticals
Lundbeck to acquire Ovation Pharmaceuticals
J&J announce filings to FDA for schizophrenia drug
J&J announce filings to FDA for schizophrenia drug
ESO recommends extended time window for Actilyse
ESO recommends extended time window for Actilyse
1 … 152 153 154 155 156 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x